Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 414-417

  Gambacciani, M ^a   Ciaponi, M ^a   Cappagli, B ^a   Piaggesi, L ^a   De Simone, L ^a   Orlandi, R ^b   Genazzani, A R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Schering Plough SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE;

ADULT; AGING; ARTICLE; BODY DISTRIBUTION; BODY FAT; BODY MASS; BODY WEIGHT; BONE MINERAL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DRUG EFFECT; ESTROGEN DEFICIENCY; FEMALE; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0031032354     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.2.3735     Document Type: Article

References (26)

1. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH. 1983 Relationship of body fat topography to insulin sensitivity and metabolic profiles in postmenopausal women. Metab Clin Exp. 33:68-75.
2. Evans DJ, Hoffman RG, Kalkoff RK, Kissebah AH. 1983 Relationship of androgenic activity to body topography, fat cell morphology and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 57:304-310.
3. Lapidus L, Bengtsson C, Larsson B, et al. 1984 Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 years follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J. 289:1257-1261.
4. Haarbo J, Hassager C, Schlemmer A, et al. 1990 The influence of smoking, body fat distribution, and alcohol consumption on serum lipids, lipoproteins, and apolipoproteins in early postmenopausal women. Atherosclerosis. 84:239-244.
5. Lindsay R. 1987 Estrogen therapy in the prevention and management of osteoporosis. Am J Obstet Gynecol. 156:1347.
6. Gambacciani M, Spinetti A, Taponeco F, et al. 1994 Longitudinal evaluation of premenopausal vertebral bone loss: effects of a low dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol. 8:392-394.
7. Bush TL, Barrett-Connor E. 1985 Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev. 7:80-104.
8. Lobo RA, Speroff L. 1994 International consensus conference on postmenopausal hormone therapy and the cardiovascular system. Fertil Steril. 61:592-595.
9. The Writing Group for the PEPI Trial. 1995 Effects of estrogen and estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/progestin Interventions (PEPI) trial. JAMA. 273:199-208.
10. Andrews MC. 1994 Primary care for postreproductive women: further thoughts concerning steroid replacement. Am J Obstet Gynecol. 170:936-966.
11. Ottson UB. 1984 Oral progesterone and estrogen-progesterone therapy. Effects of natural and synthetic hormones on subfractions of HDL cholesterol and liver proteins. Acta Obstet Gynecol Scand. 127:1-37.
12. Fahiaeus L, Lareson-Cohn U, Wallentin L. 1983 L-Norgestrel and progesterone have different influences on plasma lipoproteins. Eur J Clin Invest. 13:447-53.
13. Gambacciani M, Spinetti A, De Simone L, et al. 1993 The relative contribution of menopause and aging to postmenopausal vertebral osteopenia. J Clin Endocrinol Metab. 77:11-48-52.
14. Gambacciani M, Spinetti A, Taponeco F, et al. 1995 Treatment of postmenopausal vertebral osteopenia with monofluorophosphate: a long term calcium-controlled study. Osteoporosis Int 5:467-471.
15. Heiss CJ, Sanborn CF, Nichols DL, Bonnick SL, Alford BB. 1995 Association of body fat distribution, circulating sex hormones, and bone density in postmenopausal women. J Clin Endocrinol Metab. 80:5:1591-1596.
16. Wajchenberg BL, Bosco A, Martins Marone M, et al. 1995 Estimation of body fat and lean tissue distribution be dual energy x-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab. 80:2791-2794.
17. Mazess RB, Barden HS, Bisek JP, Hanson J. 1990 Dual energy x-ray absorptiometry for total body and regional bone mineral and soft tissue composition. Am J Clin Nutr. 51:1106-1112.
18. Mazess RB, Barden HS, Ohlrich ES. 1990 Skeletal and body composition effects of anorexia nervosa. Am J Clin Nutr. 52:438-441.
19. Burger HG, Dudley EC, Hopper JL, et al. 1995 The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab. 80:3537-3545.
20. Dallongeville J, Marecaux N, Isorex D, Zylberg G, Fruchart JC, Amouyel P. 1995 Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis. 118:123-133.
21. Svendsen OL, Hassager C, Bergman I, Christiansen C. 1993 Measurement of abdominal and intraabdominal fat in postmenopausal women by dual energy x-ray absorptiometry and antropometry: comparison with computerized tomography. Int J Obesity. 17:45-51.
22. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. 1991 Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 40:12:1323-1326.
23. Gambacciani M, Spinetti A, De Simone L, et al. 1995 Postmenopausal bone loss of the proximal femur: estimated contribution of menopause and aging. Menopause. 2:169-174.
24. Riis BJ, Jensen J, Christiansen C. 1987 Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy. Clin Endocrinol (Oxf). 26:327-334.
25. Jensen J, Riis BJ, Christiansen C. 1987 Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins. Br J Obstet Gynaecol. 94:138-141.
26. Gambacciani M, Spinetti A, Orlandi R, et al. 1995 Effects of a new estrogen/progestin combination in the treatment of postmenopausal syndrome. Maturitas. 22:115-120.